Cystinuria is a genetic disorder characterized by a defective reabsorption of cystine and dibasic amino acids leading to development of urinary tract calculi from childhood onward. Cystine lithiasis is known to be resistant to fragmentation. The aim was to evaluate our long-term experience with extracorporeal shockwave lithotripsy (ESWL) used as first-line urological treatment to treat cystine stones in children. We retrospectively reviewed the charts of all children who underwent ESWL for cystine stone. We assessed the 3-month stone-free rate, according to age, younger (group 1) or older (group 2) than 2 years old. Between 2003 and 2016, 15 patients with a median (IQR) age at first treatment of 48 (15-108) months underwent ESWL in monotherapy. Median age was, respectively, 15 and 108 months in each group. The median (IQR) stone burden was 2,620 (1,202-8,265) mm in group I and 4,588 (2,039-5,427) mm in group II ( = 0.96). Eleven patients had bilateral calculi. ESWL was repeated on average 2.4 times, with a maximum of 4 for patients of group I, and 4.8 times, with a maximum of 9 for group II ( > 0.05). ESWL in monotherapy was significantly more efficient to reach stone-free status for children under 2 years of age: 83% vs. 6.2% ( = 0.040). The median (IQR) follow-up of the study was 69 (42-111) months. ESWL appears as a valid urological option for the treatment of cystine stones, in young children. Even if cystine stones are known to be resistant to fragmentation, we report 83% of stone-free status at 3 months with ESWL used in monotherapy in children under 2 years old with cystinuria. In older children, the success rate is too low to recommend ESWL as a first line approach.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636798 | PMC |
| http://dx.doi.org/10.3389/fped.2021.763317 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Urolithiasis is a multifactorial condition where stone composition is critical in guiding treatment and prevention strategies. Advanced diagnostic techniques, such as infrared spectroscopy, provide precise stone analysis, enabling clinicians to tailor interventions based on specific stone types and associated metabolic abnormalities. Calcium oxalate monohydrate stones often require invasive approaches like percutaneous nephrolithotomy, while uric acid responds well to dissolution therapy.
View Article and Find Full Text PDFA study of the difference in biochemical metabolism between patients with unilateral and bilateral upper urinary tract stones.
Sci Rep
December 2024
Department of Urology, Qinghai University Affiliated Hospital, Xining, 810000, China.
Article Synopsis
- Bilateral upper urinary tract stones are more likely to cause kidney function issues compared to unilateral stones, and a study analyzed data from 555 patients to explore metabolic differences between these groups.
- The study found that male patients and those with hyperuricemia had a higher risk of developing bilateral stones, with distinct metabolic abnormalities found, including low urine volume and higher levels of uric acid and creatinine.
- Results suggest that increasing water intake can help prevent stone formation, especially in patients with elevated uric acid levels.
The potential role of Sodium/Glucose Cotransporter 2 inhibitors in the treatment of cystinuria.
Urolithiasis
November 2024
Department of Urology, University of California San Francisco, San Francisco, CA, USA.
The Maillard reaction is a non-enzymatic reaction between an amino acid and carbohydrate. We hypothesized that continuous washing of cystine stones with glucose could theoretically prevent growth of an existing cystine stone or even reduce its size leading to a decrease in stone events. Sodium/Glucose Cotransporter 2 (SGLT2) inhibitors, well known for inducing glucosuria, were used to test this hypothesis in an initial series of patients.
View Article and Find Full Text PDFDiscovery of l-Lysine Dioxalate (LH1513) as a Novel Inhibitor of Calcium Oxalate Crystallization for Hyperoxaluria.
ACS Med Chem Lett
November 2024
Department of Genetics, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, United States.
Article Synopsis
- - Hyperoxaluria leads to high levels of oxalate in urine, resulting in the formation of calcium oxalate (CaOx) kidney stones, and there's a need for better treatment options.
- - Researchers discovered a new compound, l-lysine dioxalate (LH1513), which is a stronger inhibitor of CaOx crystallization than existing substances like citrate and pyruvate.
- - A prodrug version of LH1513 shows good absorption when taken orally and has been tested in a preliminary study on mice, showing potential in preventing the formation of urinary CaOx crystals associated with hyperoxaluria.
Urinary Stone Composition Analysis of 1465 Patients: The First Series from Azerbaijan.
Arch Iran Med
November 2024
Department of Laboratory, State Security Service Military Hospital, Baku, Azerbaijan.
Article Synopsis
- - The study focuses on urinary stone disease in Azerbaijan, analyzing the composition of stones from 1,465 patients using FTIR spectroscopy over nearly a decade.
- - Findings indicate that calcium oxalate stones are the most common type at 56.2%, with uric acid stones following at 33.7%, and show variations based on age and gender.
- - The research suggests a need for customized diagnostic and treatment strategies due to the high prevalence of urinary stones, especially mixed types, highlighting the complexity of this health issue.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!